Welcome to Peptide Card of AntiTbPdb
This page displays user query in tabular form. |
CLLKKLLKK details |
Primary information | |
---|---|
ID | antitb_1234, |
Name | 24314557 |
N-Terminal modification | C(LLKK)2 |
C-Terminal Modification | CLLKKLLKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 9 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis (ATCC No. 14468) |
Cell Line | MIC = 62.5 mg/L |
Inhibition Concentration | In vitro |
Sequence | 2014 |
Cytotoxicity | Rat red blood cells (rRBCs) |
In vivo Model | NA |
Lethal Dose | Very low, i.e. 50% hemolysis concentration (HC50) > 1000 mg/L |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane-lytic mechanism |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1235, |
Name | 24314557 |
N-Terminal modification | C(LLKK)2 |
C-Terminal Modification | CLLKKLLKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 9 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis resistant agianst rifampicin |
Cell Line | MIC = 62.5 mg/L |
Inhibition Concentration | In vitro |
Sequence | 2014 |
Cytotoxicity | Rat red blood cells (rRBCs) |
In vivo Model | NA |
Lethal Dose | Very low, i.e. 50% hemolysis concentration (HC50) > 1000 mg/L |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane-lytic mechanism |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1236, |
Name | 24314557 |
N-Terminal modification | C(LLKK)2 |
C-Terminal Modification | CLLKKLLKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 9 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium bovis |
In Vitro/ In vivo | Mycobacterium bovis BCG lux |
Cell Line | MIC = 250 mg/L |
Inhibition Concentration | In vitro |
Sequence | 2014 |
Cytotoxicity | Rat red blood cells (rRBCs) |
In vivo Model | NA |
Lethal Dose | Very low, i.e. 50% hemolysis concentration (HC50) > 1000 mg/L |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane-lytic mechanism |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1237, |
Name | 24314557 |
N-Terminal modification | C(LLKK)2 |
C-Terminal Modification | CLLKKLLKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 9 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | MIC > 500 mg/L |
Inhibition Concentration | In vitro |
Sequence | 2014 |
Cytotoxicity | Rat red blood cells (rRBCs) |
In vivo Model | NA |
Lethal Dose | Very low, i.e. 50% hemolysis concentration (HC50) > 1000 mg/L |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane-lytic mechanism |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1238, |
Name | 24314557 |
N-Terminal modification | C(LLKK)2 |
C-Terminal Modification | CLLKKLLKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 9 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis CSU87 reistant to rifampicin, isoniazid, ethambutol, streptomycin and kanamycin |
Cell Line | MIC > 500 mg/L |
Inhibition Concentration | In vitro |
Sequence | 2014 |
Cytotoxicity | Rat red blood cells (rRBCs) |
In vivo Model | NA |
Lethal Dose | Very low, i.e. 50% hemolysis concentration (HC50) > 1000 mg/L |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Membrane-lytic mechanism |
Other activities | Cell envelope |
PMID | None |
Year of Publication | Antibacterial |
Tertiary Structure (Technique) | Not Predicted), |